When it comes to regulating nanotechnology, a new study reveals that the views of nanoscientists differ from those of the general public. Researchers found that while the public tends to focus on the benefits – rather than potential environmental and health risks – when making decisions about nanotechnology regulation, scientists mainly focus on potential risks and economic values.

Using the same protein molecule that scientists have used for decades to copy genetic material, researchers have developed a molecular motor for propelling DNA.

Infectious agent known as prions resist almost every method of destruction, from fire and ionizing radiation to chemical disinfectants and autoclaving. Now, however, a team of Wisconsin researchers has found that a common soil mineral, an oxidized from of manganese known as birnessite, can penetrate the prion’s armor and degrade the protein.

It”s no secret that Americans eat too much salt, a habit linked to numerous health problems. At first glance, the solution seems simple: stop eating […]

This Saturday, as hunters seek white-tailed deer in Wisconsin”s forested areas, a research team led by University of Wisconsin-Madison entomologist Susan Paskewitz will be conducting […]

As the southern pine beetle moves through the forest boring tunnels inside the bark of trees, it brings with it both a helper and a competitor. The helper is a fungus that the insect plants inside the tunnels as food for its young. But also riding along is a tiny, hitchhiking mite, which likewise carries a fungus for feeding its own larvae.

Susan Paskewitz aims to find out how many of the mosquitoes that plague us spring through fall are of the genus that carryies the West Nile Virus

When forming attitudes about embryonic stem cell research, people are influenced by a number of things. But understanding science plays a negligible role for many people.

A crisp new edition of a classic biochemistry text is now available from booksellers in college towns and online. And that means a team of UW-Madison scientists and illustrators campus can put their feet up for a while.

The structure of the life sciences industry is changing, says G. Steven Burrill, CEO of Burrill and Company, a life sciences investment firm based in San Francisco, speaking at UW-Madison on Feb. 21